Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Payables (2016 - 2026)

Cryo Cell International's Payables history spans 17 years, with the latest figure at $3.5 million for Q1 2026.

  • Quarterly results put Payables at $3.5 million for Q1 2026, up 19.48% from a year ago — trailing twelve months through Feb 2026 was $3.5 million (up 19.48% YoY), and the annual figure for FY2025 was $3.1 million, up 48.8%.
  • Payables for Q1 2026 was $3.5 million at Cryo Cell International, up from $3.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $9.6 million in Q3 2022 to a low of $657561.0 in Q4 2023.
  • The 5-year median for Payables is $2.8 million (2025), against an average of $3.0 million.
  • The sharpest move saw Payables plummeted 69.35% in 2023, then surged 212.18% in 2024.
  • Year by year, Payables stood at $1.8 million in 2022, then plummeted by 62.55% to $657561.0 in 2023, then surged by 212.18% to $2.1 million in 2024, then surged by 48.8% to $3.1 million in 2025, then rose by 14.35% to $3.5 million in 2026.
  • According to Business Quant data, Payables over the past three periods came in at $3.5 million, $3.1 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.